MAF and systemic lupus erythematosus: Except for human findings, a previous study has suggested that murphy roths large/lymphoproliferative (MRL/lpr) lupus mice experienced reduced autoantibody levels and ameliorated clinical symptoms by impairing c‐MAF regulation in TFH cells after dexamethasone treatment.8